09 Nov 2011 Bavarian Nordic's Immunotherapy Product Candidate CV-301 Shows Promise in Breast and Ovarian Cancer
08 Nov 2011 AVIR Green Hills Biotechnology AG: deltaFLU - Innovative Vaccines for Intranasal Spray Delivery or Oral Administration
07 Nov 2011 Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
07 Nov 2011 CureVac presents clinical results of a Phase I/IIa trial in non-small cell lung cancer (NSCLC)
07 Nov 2011 SEEK announces successful Phase II challenge study of its Universal Influenza Vaccine, FLU-v
07 Nov 2011 CureVac Presents Results of a Phase I/IIa Trial in Non-Small Cell Lung Cancer (NSCLC) with CV9201, an mRNA Based Cancer Vaccine, at the 26th Annual SITC Meeting in Washington
04 Nov 2011 Galena Biopharma Presents Positive NeuVax(TM) Clinical Results at the 26th Annual Meeting of the Society for Immunotherapy of Cancer
01 Nov 2011 Alnylam and GlaxoSmithKline Form Collaboration on RNAi Technology for Vaccine Production
01 Nov 2011 Hawaii Biotech Licenses Vaccine Technology From Merck
31 Oct 2011 HAL Allergy Includes First Patient in Phase II PURETHAL® Mites Study
31 Oct 2011 PharmAthene Progresses Second Generation rPA Anthrax Vaccine
27 Oct 2011 LATUDA® (lurasidone HCl) Shown to be Non-Inferior to SEROQUEL XR® (quetiapine fumarate XR) in Risk for Relapse in a 12-Month, Double-Blind Extension Study of Adult Patients with Schizophrenia
27 Oct 2011 Pfizer Receives European Approval to Extend Use of Prevenar 13 to Adults 50 Years and Older for the Prevention of Invasive Pneumococcal Disease
27 Oct 2011 Activartis Develops Dendritic Cell-Based Therapeutic Cancer Vaccine in Phase II
26 Oct 2011 Data From Two Phase 3 Studies Demonstrate HEPLISAV's Superiority in Immunizing Persons With Diabetes From Hepatitis B
26 Oct 2011 Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials
25 Oct 2011 CDC Advisory Committee on Immunization Practices Votes for Expanded Use of GARDASIL® in Boys and Young Men
24 Oct 2011 Immunitor Publishes Phase II Immunotherapy Trial in Treatment-failed TB Patients
24 Oct 2011 Intercell announces first data from its Phase I clinical trial with vaccine candidate to prevent Clostridium difficile infections
21 Oct 2011 Sanofi Pasteur Presents New Data Confirming Fluzone High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population
21 Oct 2011 Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine
20 Oct 2011 Galena Biopharma's NeuVax (E75) Clinical Trial Results Published in Cancer
19 Oct 2011 Genticel Has Completed Recruitment of Patients for its Phase I Trial With Procervix, its Therapeutic Vaccine Against Human Papillomavirus (HPV) Types 16 and 18
18 Oct 2011 Vivalis and GeoVax Labs Enter into a Biomanufacturing Agreement for the Production Of MVA-Based Vaccines for HIV
18 Oct 2011 First Results From Ongoing Phase III Trial Show Malaria Vaccine Candidate, RTS,S* Reduces the Risk of Malaria by Half in African Children Aged 5 to 17 Months

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up